This CX Programme is subject to change.


Search for words

CX Vascular Malformations - Wednesday, 17th April
Venue:   London Room Learning Centre
Time: 13:30 - 18:00
Introduction
Time: 13:30 - 13:32
Speaker:   Fiona Rohlffs, Hamburg, Germany
Basic background and imaging
Time: 13:32 - 14:00
Chairing:   Fiona Rohlffs, Hamburg, Germany
Moderator:   Ian McCafferty, Birmingham, United Kingdom
Time: 13:32 - 13:40
ISSVA classification and what recent genetics can teach us in the management of VMs
Speaker:   Laurence Boon, Brussels, Belgium
Time: 13:40 - 13:48
The need for a classification system in the treatment of high-flow VMs
Speaker:   Fiona Rohlffs, Hamburg, Germany
Time: 13:48 - 13:56
Finding a useful classification for the treatment of low-flow VMs
Speaker:   Jocelyn Brookes, London, United Kingdom
Time: 13:56 - 14:00
Audience participation and discussion
 
Low-flow malformations
Time: 14:00 - 14:56
Chairing:   Walter Wohlgemuth, Regensburg, Germany
Moderator:   Wayne Yakes, Englewood, United States
Time: 14:00 - 14:08
Management of low-flow VMs - technique and materials
Speaker:   Walter Wohlgemuth, Regensburg, Germany
Time: 14:08 - 14:16
Results and long follow-up of treatment of low-flow VMs
Speaker:   Ian McCafferty, Birmingham, United Kingdom
Time: 14:16 - 14:24
Intraosseous vascular malformations
Speaker:   Fiona Rohlffs, Hamburg, Germany
Time: 14:24 - 14:32
Egyptian experience with capillary venous malformations
Speaker:   Tarek Radwan, Cairo, Egypt
Time: 14:32 - 14:40
Managing dangerous communications in low flow malformations - how to avoid disasters!
Speaker:   Robert Vogelzang, Chicago, United States
Time: 14:40 - 14:48
Extreme and complex venous lymphatic low-flow VM - results
Speaker:   Wayne Yakes, Englewood, United States
Time: 14:48 - 14:56
Patient radiation exposure from embolo-sclerotherapy of vascular malformations
Speaker:   Leeying Giet, London, United Kingdom
 
Debate
Time: 14:56 - 15:30
Chairing:   Fiona Rohlffs, Hamburg, Germany
Moderator:   Laurence Boon, Brussels, Belgium
Time: 14:56 - 15:20
How do we define "cure" in low-flow VMs? Can we actually "cure them" - Yes/No?
Time: 15:20 - 15:28
Rebuttal: 2 min/participant
Time: 15:24 - 15:30
Conclusion and vote
 
Tea break
Time: 15:30 - 16:00
High-flow malformations
Time: 16:00 - 16:24
Chairing:   Robert Vogelzang, Chicago, United States
Moderator:   Wayne Yakes, Englewood, United States
Time: 16:00 - 16:08
Failure to control symptomatic AVMs using polymerizing agents, salvaged by alcohol embolotherapy
Speaker:   Robert Vogelzang, Chicago, United States
Time: 16:08 - 16:16
Management of extreme AVMs
Speaker:   Wayne Yakes, Englewood, United States
Time: 16:16 - 16:24
Outcomes and follow-up of treatment of AVMs
Speaker:   Robert Vogelzang, Chicago, United States
 
Imaging
Time: 16:24 - 16:32
Time: 16:24 - 16:32
Imaging: pre- and post-treatment of VMs
Speaker:   Alex Barnacle, London, United Kingdom
 
The complimentary role of surgery in VMs
Time: 16:32 - 16:48
Chairing:   Robert Vogelzang, Chicago, United States
Moderator:   Wayne Yakes, Englewood, United States
Time: 16:32 - 16:40
Deciding whether surgery and rapamycine are friends or enemies
Speaker:   Laurence Boon, Brussels, Belgium
Time: 16:40 - 16:48
Surgical management of arteriovenous malformation
Speaker:   Laurence Boon, Brussels, Belgium
 
Case presentations: Help, I am stuck!!
Summary and closing remarks
Time: 17:48 - 18:00
Speaker:   Wayne Yakes, Englewood, United States